Alvotech (ALVOW) Research & Development (2021 - 2025)

Alvotech (ALVOW) reported Research & Development of $328.7 million for Q4 2025, up 291.87% on a YoY basis from $83.9 million in Q4 2024, and up 736.78% quarter-over-quarter from -$51.6 million in Q3 2025.

Alvotech (ALVOW) Research & Development (2021 - 2025) Analysis & Trends

Alvotech has reported Research & Development for 5 years, with the latest figure at $328.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 291.87% year-over-year to $328.7 million; the trailing twelve-month figure through Dec 2025 stood at $184.2 million (up 160.92% YoY), and the FY2025 full-year result was $184.2 million, up 7.52% from the prior year.
  • Research & Development for Q4 2025 stood at $328.7 million, up from -$51.6 million in the prior quarter.
  • The five-year high for Research & Development was $337.6 million in Q4 2021, with the low at -$210.8 million in Q4 2023.
  • Historically, Research & Development has averaged -$33.4 million across 5 years, with a median of -$50.7 million in 2025.
  • The largest YoY upside for Research & Development was 291.87% in 2025 against a maximum downside of 99900.0% in 2025.
  • Alvotech's Research & Development stood at $337.6 million in 2021, then sank by 153.5% to -$180.6 million in 2022, then declined by 16.72% to -$210.8 million in 2023, then increased by 18.74% to -$171.3 million in 2024, then jumped by 291.87% to $328.7 million in 2025.
  • The last three Research & Development figures came in at $328.7 million (Q4 2025), -$51.6 million (Q3 2025), and -$43.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 222.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 103.35 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 46.94 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 39.38 Mn
10 Alvotech - - -22.39 Mn 328.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 328.70 Mn
Sep 30, 2025 -51.62 Mn
Jun 30, 2025 -43.02 Mn
Mar 31, 2025 -49.87 Mn
Dec 31, 2024 -171.31 Mn
Sep 30, 2024 -33.57 Mn
Jun 30, 2024 -97.43 Mn
Mar 31, 2024 -49,868.00
Dec 31, 2023 -210.83 Mn
Aug 31, 2023 -99.58 Mn
Jun 30, 2023 -99.53 Mn
Mar 31, 2023 -50,864.00
Dec 31, 2022 -180.62 Mn
Aug 31, 2022 -86.88 Mn
Jun 30, 2022 -39.75 Mn
Mar 31, 2022 -47.14 Mn
Dec 31, 2021 337.61 Mn
Sep 30, 2021 -56.20 Mn